Research Seminar Series
The goal of the BEAT-CKD CRE-PACT Seminar Series is to offer patients, caregivers, clinicians, and researchers access to support in diverse research methods and opportunities for sharing knowledge, networking, and collaboration. This includes fostering partnerships between patients, caregivers, and researchers.
We’d like to invite you to the next BEAT-CKD Research Seminar Series presentation, scheduled for Monday 29th April at 2pm – 3pm (Alice Springs/SA), 2:30pm – 3:30pm (NSW/QLD/VIC) and 4:30pm – 5:30pm NZ time.
Speaker: Dr Lachlan McMichael, Kidney Specialist, Royal Adelaide Hospital, and PhD candidate.
Dr McMichael completed his clinical training at the Central and Northern Adelaide Renal and Transplantation Service and his fellowships in general nephrology and kidney transplantation at The University of British Columbia, Canada. Dr McMichael has also completed a Master of Clinical Epidemiology. His PhD research focuses on the patient pathway to kidney transplantation, with a particular focus on access to kidney transplantation and resource utilisation.
Chair: A/Prof Phil Clayton, Senior Consultant Nephrologist, Royal Adelaide Hospital, and Deputy Executive Officer, ANZDATA (Australia and New Zealand Dialysis & Transplant Registry).
A/Prof Phil Clayton completed his clinical training at Royal Prince Alfred Hospital and has completed a Master of Clinical Epidemiology, followed by a PhD in kidney transplant epidemiology. He currently balances his clinical work as a transplant nephrologist with supervision of PhD candidates and developing the technical capacity of the ANZDATA Registry.
Coordinator: Dr Georgina Irish, Transplant Nephrologist, Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital; Director of Projects and Analytics, ANZDATA; Medical Director, Transplant Australia.
Topic: Kidney transplant wait-list activation for patients with kidney failure in Australia, United Kingdom, and the United States of America.
Short description: Kidney transplantation remains the gold standard treatment for people with kidney failure. Unfortunately, there are not enough kidneys for all people to access this treatment, and variations exist in how patients are added to kidney transplant waiting lists. National registries contain rich data capturing the experience of patients with treated kidney failure. I will explore observed variations in kidney transplant wait-listing and compare the Australian experience with patients in the UK & USA.
Consumer involvement to date: Consumers have been involved in a small group workshop examining views and experiences of the kidney transplant wait-listing process.
Note to participants:
- All presentations and materials cannot be circulated without permission from the presenter.